Hamid Ahmed, CEO of Hamdard Laboratories India, has resigned as an independent director from Religare Enterprises due to ...

The court directed Sebi to decide on US resident Digvijay ‘Danny’ Gaekwad’s proposed competing offer in accordance with the ...

Florida-based businessman Danny Gaekwad seeks Trump administration intervention after lack of response from Indian regulators ...

Hamid Ahmed, CEO of Hamdard Laboratories India, has resigned from Religare Enterprises' board due to increasing workload in his family business. The resignation comes amidst a contentious open offer ...

Gaekwad sought for a special exemption under takeover from the Securities and Exchange Board of India to make an open offer ...

As the Burman family's open offer for Religare looms, a competing bid from Digvijay Gaekwad adds complexity to the situation.

Saluja had filed the petition in the high court citing the resolution is illegal and that it violates the Companies Act 2013 ...

Care Health Insurance, India’s second-largest standalone health insurer and Religare’s most valuable asset, has been growing ...

Markets took a pause after the recent rally and ended slightly lower on Wednesday. Following an initial uptick, Nifty remained range-bound throughout the session and ultimately settled at 23,686.65.

India's Religare Enterprises said a U.S. businessman has made a proposal to acquire a 26% stake in it, the latest twist in ...

While declining interim relief, the court directed SEBI to swiftly decide on a competing takeover bid, keeping the stage set ...

Orbimed Genesis Master Fund L.P. bought 45,000 shares of Mankind Pharma at Rs 2,555.1 per share, while Copthall Mauritius ...